BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 6670281)

  • 21. Treatment of parapsoriasis en plaques, mycosis fungoides, and Sézary's syndrome with trioxsalen baths followed by ultraviolet light.
    Fischer T; Skogh M
    Acta Derm Venereol; 1979; 59(2):171-3. PubMed ID: 84498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.
    Trautinger F; Knobler R; Willemze R; Peris K; Stadler R; Laroche L; D'Incan M; Ranki A; Pimpinelli N; Ortiz-Romero P; Dummer R; Estrach T; Whittaker S
    Eur J Cancer; 2006 May; 42(8):1014-30. PubMed ID: 16574401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ultrastructural observation of a case of lymphomatoid papulosis.
    Horiguchi Y; Horiguchi M; Toda K; Mitani T; Imamura S
    Acta Derm Venereol; 1984; 64(4):308-15. PubMed ID: 6209888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of high-risk human papillomaviruses in verrucae of patients with mycosis fungoides and Sézary syndrome: a case series.
    Vidulich KA; Rady PL; He Q; Tyring SK; Duvic M
    Int J Dermatol; 2009 Jun; 48(6):598-602. PubMed ID: 19538368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A comparative study of the quantitative distribution and ultrastructure of Langerhans cells in the epidermis of patients with chronic benign dermatoses and mycosis fungoides].
    Tukhvatullina ZG; Akovbian VA; Khoroshaev VA; Persina IS
    Arkh Patol; 1991; 53(5):24-8. PubMed ID: 1831968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implication of the ras and myc oncoproteins in the pathogenesis of mycosis fungoides.
    Tosca A; Linardopoulos S; Malliri A; Hatziolou E; Nicolaidou A; Spandidos DA
    Anticancer Res; 1991; 11(4):1433-8. PubMed ID: 1746900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electron microscopic identification of Langerhans cells in the dermal infiltrates of mycosis fungoides.
    Jimbow K; Chiba M; Horikoshi T
    J Invest Dermatol; 1982 Feb; 78(2):102-7. PubMed ID: 7057045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lymph node histopathologic aspects in cutaneous lymphomas of the mycosis fungoides or Sézary syndrome type. Retrospective study of 98 biopsies].
    Wechsler J; Diebold J; Gerard-Marchant R
    Ann Pathol; 1987; 7(2):122-9. PubMed ID: 3620027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrastructural characteristics of the contact zones between Langerhans cells and lymphocytes.
    Concha M; Figueroa CD; Caorsi I
    J Pathol; 1988 Sep; 156(1):29-36. PubMed ID: 3193298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.
    Saed G; Fivenson DP; Naidu Y; Nickoloff BJ
    J Invest Dermatol; 1994 Jul; 103(1):29-33. PubMed ID: 8027577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome.
    Bi MY; Curry JL; Christiano AM; Hordinsky MK; Norris DA; Price VH; Duvic M
    J Am Acad Dermatol; 2011 Jan; 64(1):53-63. PubMed ID: 21036417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
    Vinogradova IuE; Giliazitdinova EA; Zamulaeva IA; Zybunova EE; Kaplanskaia IB; Kravchenko SK; Kremenetskaia AM; Lutsenko IN; Samoĭlova RS; Selivanova EN; Sidorova IuV; Shklovskiĭ-Kord NE
    Ter Arkh; 2005; 77(10):61-5. PubMed ID: 16320688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mycosis fungoides and Sézary syndrome. A retrospective study of 60 patients with correlation between histologic classification and survival time].
    Hödl S
    Z Hautkr; 1986 Jul; 61(14):993-1013. PubMed ID: 3751216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A practical approach to accurate classification and staging of mycosis fungoides and Sézary syndrome.
    Thomas BR; Whittaker S
    Skin Therapy Lett; 2012 Dec; 17(10):5-9. PubMed ID: 23223768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.
    Moore PF; Olivry T; Naydan D
    Am J Pathol; 1994 Feb; 144(2):421-9. PubMed ID: 7906096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycosis fungoides and the Sézary syndrome.
    Kim YH; Hoppe RT
    Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of programmed death-1 (PD-1) in Sézary syndrome and mycosis fungoides.
    Cetinözman F; Jansen PM; Vermeer MH; Willemze R
    Arch Dermatol; 2012 Dec; 148(12):1379-85. PubMed ID: 23247480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lymph node localization of epidermotropic T malignant lymphomas (mycosis fungoides and Sézary's syndrome)].
    Wechsler J; Diebold J; Gérard-Marchant R
    Bull Cancer; 1984; 71(2):89-99. PubMed ID: 6610451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of cloning rearrangement of T-cell receptor gamma gene in primary cutaneous lymphoma].
    Pawlaczyk M; Kistowska M; Poreba E; Filas V; Breborowicz J; Goździcka-Józefiak A
    Pol Merkur Lekarski; 2003 Nov; 15(89):420-3. PubMed ID: 14969134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.